257 related articles for article (PubMed ID: 19659421)
1. Malaria vaccine research: lessons from 2008/9.
Haque A; Good MF
Future Microbiol; 2009 Aug; 4(6):649-54. PubMed ID: 19659421
[TBL] [Abstract][Full Text] [Related]
2. Malaria vaccines and the new malaria agenda.
Greenwood BM; Targett GA
Clin Microbiol Infect; 2011 Nov; 17(11):1600-7. PubMed ID: 21883665
[TBL] [Abstract][Full Text] [Related]
3. PATH Malaria Vaccine Initiative (MVI): perspectives on the status of malaria vaccine development.
Birkett AJ
Hum Vaccin; 2010 Jan; 6(1):139-45. PubMed ID: 20009524
[No Abstract] [Full Text] [Related]
4. The Australasian contribution to malaria vaccine development.
Redmond AM; Doolan DL
Parasite Immunol; 2010 Aug; 32(8):607-22. PubMed ID: 20626816
[TBL] [Abstract][Full Text] [Related]
5. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
6. Issues in malaria vaccine development.
Ann Stewart V; Coppel R
Parasite Immunol; 2009 Sep; 31(9):489-91. PubMed ID: 19691553
[No Abstract] [Full Text] [Related]
7. Robert Koch redux: malaria immunology in Papua New Guinea.
Stanisic DI; Mueller I; Betuela I; Siba P; Schofield L
Parasite Immunol; 2010 Aug; 32(8):623-32. PubMed ID: 20626817
[TBL] [Abstract][Full Text] [Related]
8. A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.
Good MF
Trends Parasitol; 2011 Aug; 27(8):335-40. PubMed ID: 21514227
[TBL] [Abstract][Full Text] [Related]
9. Vaccine candidates for malaria: what's new?
Takashima E; Morita M; Tsuboi T
Expert Rev Vaccines; 2016; 15(1):1-3. PubMed ID: 26559316
[TBL] [Abstract][Full Text] [Related]
10. Clinical malaria vaccine development.
Sauerwein RW
Immunol Lett; 2009 Feb; 122(2):115-7. PubMed ID: 19100773
[TBL] [Abstract][Full Text] [Related]
11. Pre-erythrocytic malaria vaccines: towards greater efficacy.
Hill AV
Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
[TBL] [Abstract][Full Text] [Related]
12. Asexual blood-stage malaria vaccine development: facing the challenges.
Genton B; Reed ZH
Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
[TBL] [Abstract][Full Text] [Related]
13. Malaria research--diversity and control: a Sweden-Japan joint seminar.
Kaneko A; Wahlgren M
Acta Trop; 2010 Jun; 114(3):129-30. PubMed ID: 20144581
[No Abstract] [Full Text] [Related]
14. Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.
Tyagi RK; Garg NK; Sahu T
J Control Release; 2012 Aug; 162(1):242-54. PubMed ID: 22564369
[TBL] [Abstract][Full Text] [Related]
15. Malaria vaccine development: persistent challenges.
Vaughan AM; Kappe SH
Curr Opin Immunol; 2012 Jun; 24(3):324-31. PubMed ID: 22521906
[TBL] [Abstract][Full Text] [Related]
16. European Vaccine Initiative: lessons from developing malaria vaccines.
Geels MJ; Imoukhuede EB; Imbault N; van Schooten H; McWade T; Troye-Blomberg M; Dobbelaer R; Craig AG; Leroy O
Expert Rev Vaccines; 2011 Dec; 10(12):1697-708. PubMed ID: 22085173
[TBL] [Abstract][Full Text] [Related]
17. Malaria vaccines: if at first you don't succeed..
Tongren JE; Zavala F; Roos DS; Riley EM
Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
[TBL] [Abstract][Full Text] [Related]
18. Malaria vaccines.
Gordon DM
Infect Dis Clin North Am; 1990 Jun; 4(2):299-313. PubMed ID: 2189001
[TBL] [Abstract][Full Text] [Related]
19. Targeting Plasmodium liver stages: better late than never.
Borrmann S; Matuschewski K
Trends Mol Med; 2011 Sep; 17(9):527-36. PubMed ID: 21737347
[TBL] [Abstract][Full Text] [Related]
20. Challenges in malaria control in sub-Saharan Africa: the vaccine perspective.
Lusingu JP; Von Seidlein L
Tanzan J Health Res; 2008 Oct; 10(4):253-66. PubMed ID: 19402588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
